Interactions médicamenteuses
Nivolumab + Rozanolixizumab
Gravité: Modérée
Nivolumab and Rozanolixizumab: moderate interaction.
Dernière mise à jour
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
Résumé
Rozanolixizumab blocks the neonatal Fc receptor, which normally protects IgG antibodies from degradation. Nivolumab is an IgG4 antibody, so its clearance could increase and exposure fall, potentially weakening antitumor effect. The clinical significance is uncertain.
Ce que signifie cette interaction, en termes simples
Nivolumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Nivolumab belongs to Oncology; Rozanolixizumab belongs to Miscellaneous.
Pourquoi elle survient
Rozanolixizumab blocks FcRn-mediated IgG recycling, which may accelerate catabolism of IgG-based nivolumab.
Conduite à tenir
Avoid combining where possible, or monitor tumor response closely if rozanolixizumab is necessary. Involve oncology and neurology specialists in weighing alternatives.
Questions à poser à votre pharmacien
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour débloquer les conseils complets de prise en charge pour Nivolumab et Rozanolixizumab, les notes complémentaires, le détail des données probantes et le vérificateur d'interactions pour une ordonnance complète.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Autres interactions de Nivolumab
- Nivolumab + Thalidomide Majeure
- Dexamethasone-tobramycin + Nivolumab Modérée
- Dexamethasone + Nivolumab Modérée
- Efgartigimod / hyaluronidase sc + Nivolumab Modérée
- Efgartigimod alfa + Nivolumab Modérée
- Nivolumab + Ponesimod Modérée
Autres interactions de Rozanolixizumab
- Rozanolixizumab + Upadacitinib Majeure
- Abatacept + Rozanolixizumab Modérée
- Adalimumab + Rozanolixizumab Modérée
- Ado-trastuzumab + Rozanolixizumab Modérée
- Basiliximab + Rozanolixizumab Modérée
- Bevacizumab + Rozanolixizumab Modérée
Questions fréquentes
Can I take Nivolumab with Rozanolixizumab?
MediHelp rates the interaction as moderate. Nivolumab and Rozanolixizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Rozanolixizumab blocks the neonatal Fc receptor, which normally protects IgG antibodies from degradation. Nivolumab is an IgG4 antibody, so its clearance could increase and exposure fall, potentially weakening antitumor effect. The clinical significance is uncertain.
How serious is the interaction between Nivolumab and Rozanolixizumab?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining where possible, or monitor tumor response closely if rozanolixizumab is necessary. Involve oncology and neurology specialists in weighing alternatives.
What other medicines interact with Nivolumab?
MediHelp also lists interactions of Nivolumab with, for example, Thalidomide, Dexamethasone-tobramycin, Dexamethasone. The full list is on the Nivolumab page.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
